Issue published 30 December 2025 Abstract Background: To determine whether initiating a glucagon-like peptide-1 receptor agonist (GLP-1 RA) within 3 months of type 2 diabetes (T2DM) diagnosis alters the subsequent risk of overall and site-specific cancer and whether this association differs by baseline body-mass index (BMI)
Arakawa R, Febres G, Cheng B, Krikhely A, Bessler M, Korner J
Samples collection After twenty-four hours from the last dose, rats of all groups were physically anesthetized by decapitation by applying pressure at the base of the skull and pulling of the tail to dislocate the neck, and then they were dissected
Available through most online providers
The main difference is that Wegovy is a standardized, FDA-approved commercial product, while compounded semaglutide is a custom-prepared medication made in regulated compounding pharmacies